US Broker Ratings

Kaltura, Inc. (KLTR) Stock Analysis: Exploring a 113% Potential Upside for Tech Investors

Kaltura, Inc. (KLTR) is capturing the attention of tech investors with a remarkable potential upside of 113.41%, according to analyst ratings. As a leading player in the software application industry,..

Canopy Growth Corporation (CGC) Investor Outlook: Exploring a 221% Potential Upside

Canopy Growth Corporation (NASDAQ: CGC), a notable player in the healthcare sector’s specialty and generic drug manufacturing industry, has been a focal point for investors interested in the burgeoning cannabis..

Pacific Biosciences of California (PACB): Analyst Consensus and Potential 26% Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a key player in the healthcare sector’s medical device industry, has been making waves with its innovative sequencing solutions. The company’s focus on..

Materialise NV (MTLS) Stock Analysis: Exploring a 63.4% Potential Upside for This Belgian 3D Printing Innovator

Materialise NV (NASDAQ: MTLS), a prominent player in the technology sector specializing in software applications and 3D printing services, commands attention with its compelling growth narrative and impressive analyst outlook...

TotalEnergies SE (TTE) Stock Analysis: Unpacking the Energy Giant’s 5.60% Dividend Yield and Growth Potential

TotalEnergies SE (TTE), a titan in the integrated oil and gas industry, has been making waves in the energy sector. With a market capitalization of $140.29 billion, this French heavyweight..

Neurogene Inc. (NGNE) Stock Analysis: Exploring a 186% Potential Upside in the Biotech Arena

For investors with a keen interest in the biotechnology sector, Neurogene Inc. (NASDAQ: NGNE) presents an intriguing opportunity. Specializing in genetic medicines for rare neurological diseases, this clinical-stage biotech firm..

Nerdy Inc. (NRDY) Stock Analysis: Exploring the 110% Potential Upside in Online Learning

As the landscape of education continues to evolve, Nerdy Inc. (NYSE: NRDY) stands at a pivotal junction, leveraging its innovative platform to reshape online learning. With a market cap of..

Alumis Inc. (ALMS) Stock Analysis: Biotechnology Innovator with Over 100% Upside Potential

Alumis Inc. (NASDAQ: ALMS), a burgeoning name in the biotechnology sector, is drawing attention from investors with its promising pipeline and potential for substantial upside. This clinical-stage biopharmaceutical company is..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A Look at the 136.84% Potential Upside

Alpha Teknova, Inc. (NASDAQ: TKNO) is making waves in the healthcare sector with its innovative approach to supplying critical reagents essential for the development of novel therapies and diagnostics. The..

A2Z Cust2Mate Solutions Corp. (AZ) Stock Analysis: Unveiling a 207% Potential Upside in the Smart Cart Sector

A2Z Cust2Mate Solutions Corp. (AZ), a Canadian technology company traded on an undisclosed exchange, is making waves in the Software – Application industry with its innovative retail automation solutions. With..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring a Stunning 456% Potential Upside

Investors seeking opportunities in the biotechnology sector may find aTyr Pharma, Inc. (NASDAQ: ATYR) an intriguing candidate, particularly given its notable potential upside of 456.40%. As a clinical-stage biotechnology company,..

Aura Biosciences, Inc. (AURA) Stock Analysis: A Look at Its 255.96% Potential Upside

Aura Biosciences, Inc. (NASDAQ: AURA) presents an intriguing opportunity for investors in the dynamic biotechnology sector. The company, headquartered in Boston, Massachusetts, specializes in developing precision therapies for solid tumors...

SoundHound AI, Inc. (SOUN) Stock Analysis: Potential Upside and Growth in the AI Sector

SoundHound AI, Inc. (NASDAQ: SOUN) has emerged as a noteworthy player within the technology sector, specializing in the development of independent voice AI solutions. With a market capitalization of $4.19..

Phathom Pharmaceuticals (PHAT) Stock Analysis: A Biotech with 38% Upside Potential

Phathom Pharmaceuticals, Inc. (PHAT), a rising player in the biotechnology sector, is capturing investor attention with its promising focus on gastrointestinal treatments. The company’s market capitalization stands at $1.18 billion,..

Quhuo Limited (QH) Investor Outlook: Navigating Challenges in the Gig Economy Landscape

Quhuo Limited – American Depositary Shares (QH), a player in the technology sector, operates a comprehensive gig economy platform for life services in China. Despite its innovative approach to on-demand..

Erasca, Inc. (ERAS) Investor Outlook: A Promising 37.77% Upside Potential in Precision Oncology

Erasca, Inc. (NASDAQ: ERAS) has garnered significant attention from investors with its focus on precision oncology and its promising pipeline of therapies targeting RAS/MAPK pathway-driven cancers. As a clinical-stage biotechnology..

Quantum-Si Incorporated (QSI) Stock Analysis: Potential Upside of 143.94% Sparks Investor Interest

Quantum-Si Incorporated (NASDAQ: QSI), a trailblazer in the healthcare sector, specifically within the medical devices industry, has been drawing attention with its pioneering work in Next Generation Protein Sequencing (NGPS)...

Outset Medical, Inc. (OM) Stock Analysis: A Deep Dive into its 257% Potential Upside

Outset Medical, Inc. (NASDAQ: OM) is an intriguing player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $67.35 million, Outset Medical focuses on..

Neuronetics, Inc. (STIM) Stock Analysis: Exploring the 371% Upside Potential in Healthcare

Neuronetics, Inc. (NASDAQ: STIM), a prominent player in the healthcare sector, specifically within the medical devices industry, is garnering significant attention from investors due to its compelling potential upside of..

Immutep Limited (IMMP) Stock Analysis: Exploring a Potential 232% Upside in Biotech Innovations

Immutep Limited (NASDAQ: IMMP), an Australian biotechnology firm, has captured the interest of investors with its pioneering work in immunotherapy, specifically targeting the Lymphocyte Activation Gene-3 (LAG-3) pathway. As the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds